Skip to main content
Displaying 1 - 12 of 26
Display:
12
24
48
Immune-Mediated and Cholestatic Diseases
GSK: "Investigating IBAT inhibition in itch – a new tool for an age-old problem?" (Complete Session)
Webcasts
View
Immune-Mediated and Cholestatic Diseases
GSK: "Practical tips towards providing holistic care to patients with PBC" (Complete Session)
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Albireo Pharma, an Ipsen Company: “New Horizons in cholestatic liver disease” (Complete Session)
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Ipsen: "Scratching beyond the surface in PBC: From current unmet medical needs to future prospects" (Complete Session)
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Mirum Pharmaceuticals, Inc: "Meet the Experts in Cholestatic Liver Disease" (Complete Session)
Webcasts
View
Immune-Mediated and Cholestatic Diseases
What is the unmet burden of itch from an HCP perspective?
Webcasts
View
Immune-Mediated and Cholestatic Diseases
How can we face itch in the present?
Webcasts
View
Immune-Mediated and Cholestatic Diseases
What is the unmet burden of itch from a patient perspective?
Webcasts
View
Immune-Mediated and Cholestatic Diseases
IBAT inhibition: a tool for the future?
Webcasts
View
Immune-Mediated and Cholestatic Diseases
What are the unmet needs in PBC according to a patient advocate?
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Why is holistic care important for patients with PBC?
Webcasts
View
Immune-Mediated and Cholestatic Diseases
What can we learn about holistic care to manage cholestatic pruritus in PBC from a UK healthcare setting?
Webcasts
View
Pagination
Current page
1
Page
2
Page
3
Next page
next ›
Last page
Last »
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Content Access policy
Privacy Policy
Cookie Policy